138 related articles for article (PubMed ID: 26375045)
1. Abnormal Biochemical Analytes Used for Aneuploidy Screening and Adverse Pregnancy Outcomes in Twin Gestations.
Rosner JY; Fox NS; Saltzman D; Klauser CK; Rebarber A; Gupta S
Am J Perinatol; 2015 Dec; 32(14):1331-5. PubMed ID: 26375045
[TBL] [Abstract][Full Text] [Related]
2. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
3. First and second trimester markers of fetal aneuploidy in pregnant women with HIV infection.
Spencer K
Fetal Diagn Ther; 2011; 29(2):135-8. PubMed ID: 20714121
[TBL] [Abstract][Full Text] [Related]
4. First-Trimester and Second-Trimester Maternal Serum Biomarkers as Predictors of Placental Abruption.
Ananth CV; Wapner RJ; Ananth S; D'Alton ME; Vintzileos AM
Obstet Gynecol; 2017 Mar; 129(3):465-472. PubMed ID: 28178056
[TBL] [Abstract][Full Text] [Related]
5. Decreased first-trimester maternal serum free-beta subunit human chorionic gonadotropin and preterm birth in twin gestations.
Laughon SK; Rebarber A; Rolnitzky L; Fink L; Saltzman DH
Am J Perinatol; 2009 Aug; 26(7):491-4. PubMed ID: 19288397
[TBL] [Abstract][Full Text] [Related]
6. First trimester predictors of adverse pregnancy outcomes.
Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
[TBL] [Abstract][Full Text] [Related]
7. First- and second-trimester maternal serum markers of pre-eclampsia in twin pregnancy.
Svirsky R; Levinsohn-Tavor O; Feldman N; Klog E; Cuckle H; Maymon R
Ultrasound Obstet Gynecol; 2016 May; 47(5):560-4. PubMed ID: 25865365
[TBL] [Abstract][Full Text] [Related]
8. Multivariate analysis identifies the estradiol level at ovulation triggering as an independent predictor of the first trimester pregnancy-associated plasma protein-A level in IVF/ICSI pregnancies.
Giorgetti C; Vanden Meerschaut F; De Roo C; Saunier O; Quarello E; Hairion D; Penaranda G; Chabert-Orsini V; De Sutter P
Hum Reprod; 2013 Oct; 28(10):2636-42. PubMed ID: 23887070
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of combined serum biomarkers for adverse pregnancy outcomes.
Cohen JL; Smilen KE; Bianco AT; Moshier EL; Ferrara LA; Stone JL
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():89-94. PubMed ID: 25129153
[TBL] [Abstract][Full Text] [Related]
10. First-trimester or second-trimester screening, or both, for Down's syndrome.
Malone FD; Canick JA; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Bianchi DW; Rudnicka AR; Hackshaw AK; Lambert-Messerlian G; Wald NJ; D'Alton ME;
N Engl J Med; 2005 Nov; 353(19):2001-11. PubMed ID: 16282175
[TBL] [Abstract][Full Text] [Related]
11. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery.
Spencer K; Cowans NJ; Molina F; Kagan KO; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Feb; 31(2):147-52. PubMed ID: 17992705
[TBL] [Abstract][Full Text] [Related]
12. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
13. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome.
Huang T; Hoffman B; Meschino W; Kingdom J; Okun N
Prenat Diagn; 2010 May; 30(5):471-7. PubMed ID: 20440736
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of maternal serum AFP to PAPP-A or b-hCG ratios in spontaneous preterm birth.
Celik E; Melekoğlu R; Baygül A; Kalkan U; Şimşek Y
J Obstet Gynaecol; 2022 Aug; 42(6):1956-1961. PubMed ID: 35620869
[TBL] [Abstract][Full Text] [Related]
15. Obstetrical complications associated with first-trimester screening markers in twin pregnancies.
Iskender C; Tarım E; Çok T; Yalcınkaya C; Kalaycı H; Yanık FB
J Obstet Gynaecol Res; 2013 Nov; 39(11):1495-9. PubMed ID: 23855638
[TBL] [Abstract][Full Text] [Related]
16. Maternal serum analyte screening for fetal aneuploidy.
Chasen ST
Clin Obstet Gynecol; 2014 Mar; 57(1):182-8. PubMed ID: 24488056
[TBL] [Abstract][Full Text] [Related]
17. The impact of assisted reproductive technology on the association between first-trimester pregnancy-associated plasma protein a and human chorionic gonadotropin and adverse pregnancy outcomes.
Zhong Y; Bradshaw R; Stanley AP; Odibo AO
Am J Perinatol; 2011 May; 28(5):347-54. PubMed ID: 21082535
[TBL] [Abstract][Full Text] [Related]
18. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of dried blood alpha fetoprotein into traditional first trimester Down syndrome screening service.
Carmichael J; Krantz D; Liu HP; Janik D; Hallahan T
Prenat Diagn; 2015 Jul; 35(7):703-8. PubMed ID: 25846256
[TBL] [Abstract][Full Text] [Related]
20. Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia.
Olsen RN; Woelkers D; Dunsmoor-Su R; Lacoursiere DY
Am J Obstet Gynecol; 2012 Sep; 207(3):228.e1-7. PubMed ID: 22818876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
